Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial

Clinical Nutrition

Volumn 34, Issue 3, 2015, Pages 388-393

  Samimi, Mansooreh ^a   Jamilian, Mehri ^b   Asemi, Zatollah ^a   Esmaillzadeh, Ahmad ^c,d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gestational diabetes; Omega 3 fatty acid; Pregnant women; Supplementation

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; ANTIOXIDANT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE SCORE; HOMEOSTATIC MODEL ASSESSMENT BETA CELL FUNCTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INTERVENTION STUDY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREGNANCY DIABETES MELLITUS; PROTEIN DEGRADATION; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ADOLESCENT; BLOOD; BODY MASS; BODY WEIGHT; DIABETES, GESTATIONAL; DIET RESTRICTION; IRAN; METABOLISM; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIOXIDANTS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; IRAN; PREGNANCY; TRIGLYCERIDES; YOUNG ADULT;

EID: 84928203498     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.06.005     Document Type: Article

References (30)

1. Zhou S.J., Yelland L., McPhee A.J., Quinlivan J., Gibson R.A., Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012, 95:1378-1384.
2. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
3. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., et al. Hyperglycemia and adverse pregnancy outcomes. NEngl J Med 2008, 358:1991-2002.
4. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. JClin Invest 1997, 100:2680-2690.
5. Kusters D.M., Homsma S.J., Hutten B.A., Twickler M.T., Avis H.J., van der Post J.A., et al. Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy. Neth J Med 2010, 68:299-303.
6. Louie J.C., Markovic T.P., Perera N., Foote D., Petocz P., Ross G.P., et al. Arandomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care 2011, 34:2341-2346.
7. Asemi Z., Samimi M., Tabassi Z., Sabihi S.S., Esmaillzadeh A. Arandomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition 2013, 29:619-624.
8. Khattab S., Mohsen I.A., Aboulfoutouh I., Ashmawi H.S., Mohsen M.N., van Wely M., et al. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 2011, 27:789-793.
9. Maymone A.C., Baillargeon J.P., Menard J., Ardilouze J.L. Oral hypoglycemic agents for gestational diabetes mellitus?. Expert Opin Drug Saf 2011, 10:227-238.
10. Min Y., Nam J.H., Ghebremeskel K., Kim A., Crawford M. Adistinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study. Diabetes Res Clin Pract 2006, 73:178-183.
11. Bitsanis D., Ghebremeskel K., Moodley T., Crawford M.A., Djahanbakhch O. Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 2006, 41:341-346.
12. Wang Y., Storlien L.H., Jenkins A.B., Tapsell L.C., Jin Y., Pan J.F., et al. Dietary variables and glucose tolerance in pregnancy. Diabetes Care 2000, 23:460-464.
13. Bo S., Menato G., Lezo A., Signorile A., Bardelli C., De Michieli F., et al. Dietary fat and gestational hyperglycaemia. Diabetologia 2001, 44:972-978.
14. Mohammadi E., Rafraf M., Farzadi L., Asghari-Jafarabadi M., Sabour S. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 2012, 21:511-518.
15. Oliveira J.M., Rondo P.H., Yudkin J.S., Souza J.M., Pereira T.N., Catalani A.W., et al. Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial. Int J STD AIDS 2014, 25:96-104.
16. Higuchi T., Shirai N., Saito M., Suzuki H., Kagawa Y. Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids. JNutr Biochem 2008, 19:577-586.
17. Nestel P.J. Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 2000, 71:228S-231S.
18. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
19. Lu J., Borthwick F., Hassanali Z., Wang Y., Mangat R., Ruth M., et al. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR: LA-cp rat model of the metabolic syndrome. Br J Nutr 2011, 105:1572-1582.
20. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl.1):S81-S90.
21. Fakhrzadeh H., Ghaderpanahi M., Sharifi F., Mirarefin M., Badamchizade Z., Kamrani A.A., et al. The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: a randomized controlled clinical trial. Int J Vitam Nutr Res 2010, 80:107-116.
22. Sarbolouki S., Javanbakht M.H., Derakhshanian H., Hosseinzadeh P., Zareei M., Hashemi S.B., et al. Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial. Singap Med J 2013, 54:387-390.
23. Fetter J.C., Brunette M., Green A.I. N-3 fatty acids for hypertriglyceridemia in patients taking second-generation antipsychotics. Clin Schizophr Relat Psychoses 2013, 7:73A-77A.
24. Kondo K., Morino K., Nishio Y., Kondo M., Fuke T., Ugi S., et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. JAtheroscler Thromb 2010, 17:628-637.
25. Bellenger J., Bellenger S., Bataille A., Massey K.A., Nicolaou A., Rialland M., et al. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011, 60:1090-1099.
26. Poulia K.A., Panagiotakos D.B., Tourlede E., Rezou A., Stamatiadis D., Boletis J., et al. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. JRen Nutr 2011, 21:479-484.
27. Zulyniak M.A., Perreault M., Gerling C., Spriet L.L., Mutch D.M. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men. Metabolism 2013, 62:1107-1113.
28. Bell S., Cooney J., Packard C.J., Caslake M.J., Deighan C.J. The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria. Clin Nephrol 2012, 77:445-453.
29. Colquhoun A., Schumacher R.I. Gamma-linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells. Biochim Biophys Acta 2001, 1533:207-219.
30. Shaneshin M., Rashidkhani B., Rabiei S. Accuracy of energy intake reporting: comparison of energy intake and resting metabolic rate and their relation to anthropometric and sociodemographic factors among Iranian women. Arch Iran Med 2012, 15:681-687.